Response to chemotherapy in patients with lung metastases: How many nodules should be measured?

Cancer Imaging

Volumn 6, Issue 1, 2006, Pages 107-112

  Chojniak, R ^a   Yu, L S ^a   Younes, R N ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Antineoplastic chemotherapy; Computed tomography; FDA drug evaluation; Protocols Phase II

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; RADIOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 33746319605     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2006.0017     Document Type: Article

References (13)

1. Chu E, DeVita VT Jr. Chemotherapy as part of the initial treatment of cancer. In: Cancer: Principles and Practice of Oncology, 6th edn. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia, PA: Lippincott, Williams & Wilkins, 2001: 290.
2. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14. (Pubitemid 11167383)
3. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-16. (Pubitemid 30099779)
4. Davis SD. CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology 1991; 180: 1-12.
5. Fidler IJ, Poste G. The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol 1985; 12: 207-21. (Pubitemid 16214550)
6. Chojniak R, Younes RN. Pulmonary metastases tumor doubling time: assessment by computed tomography. Am J Clin Oncol 2003; 26: 374-7. (Pubitemid 36962081)
7. Altman DG. Practical Statistics for Medical Research, Inter-rater agreement. London: Chapman & Hall, 1991: 403-9.
8. Prasad SR, Saini S, Sumner JE, Hahn PF, Sahani D, Boland GW. Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines. J Comput Assist Tomogr 2003; 27: 380-4. (Pubitemid 36793188)
9. Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt- Gray MF et al. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol 2004; 11: 1355-60. (Pubitemid 39642822)
10. Gurland J, Johnson RO. How reliable are tumor measurements? JAMA 1965; 194: 125-30.
11. Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: 2574-82. (Pubitemid 46606340)
12. Thiesse P, Ollivier L, Di Stefano-Louineau D, Negrier S, Savary J, Pignard K et al. Response rate accuracy in oncologic trials: reasons for interobserver variability. J Clin Oncol 1997; 15: 3507-14. (Pubitemid 27527724)
13. Bogot NR, Kazerooni EA, Kelly AM, Quint LE, Desjardins B, Nan B. Interobserver and intraobserver variability in the assessment of pulmonary nodule size on CT using film and computer display methods. Acad Radiol 2005; 12: 948-56.